Stockscreener 앱 받기
4.59
2.23%
0.10
전일 마감가:
$4.49
열려 있는:
$4.5
하루 거래량:
4.21M
Relative Volume:
1.32
시가총액:
$1.41B
수익:
$248.37M
순이익/손실:
$11.74M
주가수익비율:
91.80
EPS:
0.05
순현금흐름:
$18.24M
1주 성능:
+11.68%
1개월 성능:
+20.16%
6개월 성능:
-12.24%
1년 성능:
-27.49%
1일 변동 폭
$4.50
$4.62
1주일 범위
$3.76
$4.62
52주 변동 폭
$3.3812
$7.63
맨카인드 Stock (MNKD) Company Profile
명칭
Mannkind Corp
전화
818-661-5000
주소
1 CASPER STREET, DANBURY, CA
MNKD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
4.59 | 1.38B | 248.37M | 11.74M | 18.24M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
맨카인드 Stock (MNKD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-16 | 재개 | H.C. Wainwright | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-10 | 개시 | Wedbush | Outperform |
| 2024-12-20 | 개시 | Wells Fargo | Overweight |
| 2024-12-19 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-10-10 | 개시 | Wedbush | Outperform |
| 2021-05-14 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-24 | 개시 | Oppenheimer | Outperform |
| 2019-10-25 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-05-14 | 개시 | BTIG Research | Buy |
| 2019-03-04 | 개시 | SVB Leerink | Outperform |
| 2019-02-22 | 개시 | SVB Leerink | Outperform |
| 2018-02-28 | 다운그레이드 | Maxim Group | Hold → Sell |
| 2017-11-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2017-10-10 | 개시 | H.C. Wainwright | Buy |
| 2017-10-06 | 재확인 | Maxim Group | Buy |
| 2017-08-11 | 개시 | Maxim Group | Buy |
| 2016-05-10 | 재확인 | Piper Jaffray | Underweight |
| 2016-05-10 | 재확인 | RBC Capital Mkts | Underperform |
| 2016-01-06 | 재확인 | Piper Jaffray | Underweight |
| 2016-01-06 | 재확인 | RBC Capital Mkts | Underperform |
| 2015-11-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Underperform |
| 2015-09-09 | 다운그레이드 | Piper Jaffray | Neutral → Underweight |
| 2015-08-03 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-05-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2015-05-11 | 재확인 | MLV & Co | Hold |
| 2015-04-16 | 재확인 | RBC Capital Mkts | Outperform |
모두보기
맨카인드 주식(MNKD)의 최신 뉴스
Trend analysis for MannKind Corporation this week2025 Big Picture & Fast Gain Swing Alerts - Newser
How to recover losses in MannKind Corporation stockQuarterly Profit Review & Consistent Profit Trading Strategies - Newser
Can trapped investors hope for a rebound in MannKind Corporation2025 Earnings Surprises & Technical Pattern Recognition Alerts - Newser
Applying chart zones and confluence areas to MannKind CorporationInflation Watch & Safe Entry Point Identification - Newser
Forecasting MannKind Corporation price range with options dataWeekly Risk Report & High Conviction Trade Alerts - Newser
What to expect from MannKind Corporation in the next 30 days2025 Major Catalysts & High Yield Equity Trading Tips - Newser
Published on: 2025-08-31 07:53:49 - Newser
When is the best time to exit MannKind CorporationMarket Sentiment Summary & Safe Entry Zone Tips - Newser
How to integrate MannKind Corporation into portfolio analysis toolsPortfolio Return Summary & Real-Time Buy Signal Notifications - Newser
Applying sector rotation models to MannKind CorporationWeekly Investment Report & Weekly High Conviction Ideas - Newser
MannKind Corporation stock trend forecastJuly 2025 Outlook & AI Enhanced Trading Signals - Newser
Published on: 2025-08-30 22:04:25 - Newser
How MannKind Corporation stock performs during market volatilityJuly 2025 Review & Real-Time Chart Breakout Alerts - Newser
Is now a turning point for MannKind Corporation2025 Short Interest & Risk Adjusted Buy and Sell Alerts - Newser
Historical volatility pattern of MannKind Corporation visualizedTrade Risk Assessment & Low Risk High Win Rate Picks - Newser
Full technical analysis of MannKind Corporation stockMarket Activity Report & Weekly Return Optimization Plans - Newser
Using fundamentals and technicals on MannKind CorporationVolume Spike & AI Driven Stock Reports - Newser
Does MannKind Corporation show high probability of reboundQuarterly Trade Report & Fast Moving Stock Watchlists - Newser
MannKind Buys scPharmaceuticals For $360 Million Bet: Can This Transform Its Future In Cardiorenal Care? - Smartkarma
Has MannKind Corporation formed a bullish divergence2025 Technical Patterns & AI Driven Price Predictions - Newser
Is MannKind Corporation stock reversal real or fakeWeekly Risk Report & Verified Entry Point Signals - Newser
Does MannKind Corporation fit your quant trading model2025 Price Action Summary & Reliable Price Breakout Alerts - Newser
MannKind to acquire scPharmaceuticals stock in $303 million deal, H.C. Wainwright downgrades - Investing.com
MannKind Corporation (MNKD) Seeks FDA Pediatric Approval for Afrezza - Insider Monkey
Published on: 2025-08-28 23:17:11 - Newser
맨카인드 (MNKD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
맨카인드 주식 (MNKD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Thomson David | EVP Genl Counsel & Secretary |
Jul 16 '25 |
Sale |
3.94 |
7,466 |
29,416 |
841,719 |
0.96%
1.09%
자본화:
|
볼륨(24시간):